CAMP4 Therapeutics Corp. (CAMP)
4.45
-0.01
(-0.22%)
USD |
NASDAQ |
May 11, 16:00
4.45
0.00 (0.00%)
After-Hours: 17:32
CAMP4 Therapeutics EPS Diluted (Quarterly) : -0.3165 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | -1.026 |
| Tyra Biosciences, Inc. | -0.5655 |
| Entrada Therapeutics, Inc. | -0.9493 |
| Fate Therapeutics, Inc. | -0.2715 |
| Praxis Precision Medicines, Inc. | -3.205 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.33M |
| Revenue (Quarterly) | 1.294M |
| Total Expenses (Quarterly) | 19.62M |
| Enterprise Value | 133.77M |
| Gross Profit Margin (Quarterly) | 59.81% |
| Profit Margin (Quarterly) | -1.42K% |
| Earnings Yield | -51.03% |
| Normalized Earnings Yield | -39.53 |